Found 7 matching trials
Relative Bioavailability Study of SHR3680
PHASE1This is a single-center, single-dose, randomized, open-label, parallel sstu...
Location
The Second Affiliated Hospital of Guangzhou Medical University
A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects
PHASE1The purpose of this study is to determine whether daily treatment with SHR3...
Location
Cancer Hospital of Tianjin
A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC
PHASE1The aim of this trial is to study the tolerance, pharmacokinetics (PK) and ...
Location
Fudan University Shanghai Cancer Center
A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
PHASE2This is a phase II, multicentre clinical study investigating HS-20093 or SH...
Location
Nanjing Drum Tower Hospital
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
PHASE3The aim of this study is to compare the safety and efficacy of SHR3680 with...
Location
Complex oncological center - Bourgas
A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC
PHASE2The aim of this trial is to evaluate SHR3680 combined with SHR3162 and SHR3...
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
PHASE1This study evaluates the tolerability, safety, pharmacokinetics and efficac...